Top 17 Karyopharm Therapeutics investors
The most complete profiles first. Showing 17 of 17.
Brett ZbarVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedInvestment ManagementPortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 68 more
Verified email available
Dennis RyanVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedLife SciencePortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Verified email available
Dorothy MargolskeeVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedLife SciencePortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Verified email available
Matt TaylorVerified
Venture Capital, Advisor, Private Equity Firm · United Kingdom
SeedHealth CareHospitalsWomen FoundedLife SciencePortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Verified email available
Rhonda KaufmanVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedLife SciencePortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Verified email available
Matthew PotterVerified
Venture Capital, Investor · United States
Health CareData IntegrationWearablesAutonomous VehiclesPortfolio: BARRX Medical, Lutonix, Karyopharm Therapeutics, Vital Therapies and 48 more
Verified email available
Ron HuntVerified
Venture Capital, Private Equity Firm · United States
Health CareCybersecurityMessagingWomen FoundedPortfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more
Verified email available
Luke Bagaason, CFA
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedInvestment ManagementPortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Contact details available
Richard Lau, CFA
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedInvestment ManagementPortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Contact details available
Craig Slutzkin
Venture Capital, Private Equity Firm · United States
Health CareCybersecurityMessagingWomen FoundedPortfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more
Contact details available
Deepa Pakianathan Ph.D.
Venture Capital, Private Equity Firm · United States
Health CareData IntegrationWearablesAutonomous VehiclesPortfolio: BARRX Medical, Lutonix, Karyopharm Therapeutics, Vital Therapies and 48 more
Contact details available
Doug Roeder
Venture Capital · United States
Health CareData IntegrationWearablesAutonomous VehiclesPortfolio: BARRX Medical, Lutonix, Karyopharm Therapeutics, Vital Therapies and 48 more
Contact details available
James Niedel
Venture Capital, Private Equity Firm · United States
Health CareCybersecurityMessagingWomen FoundedPortfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more
Contact details available
Jeffrey Ives
Venture Capital · United States
Health CareCybersecurityMessagingWomen FoundedPortfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more
Contact details available
Rebecca Luse
Venture Capital · United States
Health CareCybersecurityMessagingWomen FoundedPortfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more
Contact details available
Vijay Lathi
Venture Capital, Private Equity Firm · United States
Health CareCybersecurityMessagingWomen FoundedPortfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more
Contact details available
Jonathan Sands
Angel/Individual · United States
Health CareE-commerceEnterprise SoftwareMobilePortfolio: Karyopharm Therapeutics, Koio, Backplane, Eventscom and 2 more
Contact details available
Frequently asked questions
How many Karyopharm Therapeutics investors are on Angel Roster?
Angel Roster lists 17 Karyopharm Therapeutics investors. 7 of them (41%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (16), Private Equity Firms (12) and Angel Investors (1). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Karyopharm Therapeutics investors invest in?
Among those that list a stage, the most common are Seed (7).
Where are Karyopharm Therapeutics investors based?
Most are based in the United States (16) and the United Kingdom (1).
Which companies have Karyopharm Therapeutics investors backed?
The most-backed portfolio companies among them are Alector (13), Wave Life Sciences (13), Intarcia Therapeutics (13), Ivantis (10) and Relypsa (9).
How do I contact Karyopharm Therapeutics investors?
Create a free Angel Roster account to search and filter all 17, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.